X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (91) 91
humans (90) 90
cardiac & cardiovascular systems (72) 72
female (70) 70
male (69) 69
cardiovascular (59) 59
middle aged (57) 57
percutaneous coronary intervention (50) 50
aged (47) 47
clopidogrel (42) 42
prasugrel (41) 41
ticagrelor (40) 40
cardiac patients (37) 37
treatment outcome (33) 33
acute coronary syndromes (32) 32
prospective studies (32) 32
coronary heart disease (31) 31
internal medicine (30) 30
adenosine - analogs & derivatives (28) 28
care and treatment (28) 28
acute coronary syndrome (26) 26
outcomes (22) 22
platelet aggregation inhibitors - adverse effects (22) 22
platelet aggregation inhibitors - therapeutic use (22) 22
platelet aggregation inhibitors - administration & dosage (21) 21
ticlopidine - analogs & derivatives (21) 21
adenosine - administration & dosage (20) 20
inhibition (20) 20
intervention (20) 20
heart attacks (19) 19
analysis (18) 18
risk factors (18) 18
time factors (18) 18
acute coronary syndrome - drug therapy (17) 17
platelet activation - drug effects (17) 17
platelet reactivity (17) 17
prasugrel hydrochloride (17) 17
registries (17) 17
abridged index medicus (16) 16
heart attack (16) 16
purinergic p2y receptor antagonists - administration & dosage (16) 16
purinergic p2y receptor antagonists - therapeutic use (16) 16
transluminal angioplasty (16) 16
cardiology (15) 15
mortality (15) 15
cardiology and cardiovascular medicine (14) 14
coronary angiography (14) 14
drug therapy (14) 14
hemorrhage - chemically induced (14) 14
metaanalysis (14) 14
acute coronary syndrome - therapy (13) 13
adenosine - therapeutic use (13) 13
blood platelets - drug effects (13) 13
cardiovascular disease (13) 13
pharmacology & pharmacy (13) 13
angioplasty (12) 12
impact (12) 12
myocardial infarction - therapy (12) 12
percutaneous coronary intervention - adverse effects (12) 12
purinergic p2y receptor antagonists - adverse effects (12) 12
artery-disease (11) 11
hematology (11) 11
peripheral vascular disease (11) 11
pharmacology (11) 11
platelet function tests (11) 11
platelet inhibition (11) 11
platelets (11) 11
adenosine (10) 10
adenosine - adverse effects (10) 10
myocardial infarction - blood (10) 10
percutaneous coronary intervention - methods (10) 10
therapy (10) 10
ticlopidine - adverse effects (10) 10
ticlopidine - therapeutic use (10) 10
acute coronary syndrome - surgery (9) 9
antiplatelet therapy (9) 9
blood platelets (9) 9
coronary vessels (9) 9
electrocardiography (9) 9
elevation myocardial-infarction (9) 9
greece (9) 9
management (9) 9
medical research (9) 9
multivariate analysis (9) 9
myocardial infarction - drug therapy (9) 9
patients (9) 9
piperazines - administration & dosage (9) 9
piperazines - adverse effects (9) 9
piperazines - therapeutic use (9) 9
thiophenes - administration & dosage (9) 9
thiophenes - adverse effects (9) 9
thiophenes - therapeutic use (9) 9
thrombosis (9) 9
ticlopidine - administration & dosage (9) 9
trial (9) 9
blood platelets - metabolism (8) 8
drug-eluting stents (8) 8
follow-up studies (8) 8
medicine & public health (8) 8
myocardial infarction (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 1, pp. 22 - 28
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 13, pp. 2140 - 2140
  Conclusions The predictive accuracy of platelet reactivity under novel P2Y12 receptor inhibitors is weak in the studied population. 
Cardiovascular | Internal Medicine | Clinical outcomes | Circulatory system
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 5, pp. 511 - 512
  [...]to confirm enhanced drug absorption, a pharmacokinetic analysis could also have been performed. [...]unmeasured confounder and overfitting risks cannot... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Studies | Confidence intervals | Heart attacks | Drug dosages
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 18, pp. B241 - B242
In the Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin -Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI... 
Care and treatment | Comparative analysis | Cardiac patients | Heart attack | Myocardial infarction | Clopidogrel | Infarction | Pharmacology | Heart attacks
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 12, pp. 2064 - 2069
In ST-segment elevation myocardial infarction (STEMI), an effective antiplatelet treatment adjunctive to primary percutaneous coronary intervention is of... 
Cardiovascular | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | CANGRELOR | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | TICAGRELOR | CARDIOVASCULAR EVENTS | DOUBLE-BLIND | TREATMENT PLATELET REACTIVITY | PRASUGREL | PRIMARY PCI | Myocardial Infarction - mortality | Prognosis | Purinergic P2Y Receptor Antagonists - administration & dosage | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Dose-Response Relationship, Drug | Myocardial Infarction - therapy | Purinergic P2Y Receptor Antagonists - adverse effects | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Electrocardiography - methods | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Hemorrhage - epidemiology | Risk Assessment | Administration, Oral | Treatment Outcome | Combined Modality Therapy | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Survival Analysis | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Transluminal angioplasty | Care and treatment | Analysis | Cardiac patients | Heart attack | Intervention | Stroke | Heart attacks | Heart surgery | Mortality | Thrombosis | Studies | Confidence intervals | Ischemia | Blood platelets | Coronary vessels | Drug therapy | Acute coronary syndromes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 22, pp. 2436 - 2436
  Adenosine-induced dyspnea is indeed significantly augmented with ticagrelor on board, although it is self-limiting and of questionable clinical relevance.... 
Cardiovascular | Internal Medicine | Care and treatment | Adenosine | Coronary heart disease | Cardiac patients | Plasma | Flow velocity | Acute coronary syndromes | Drug therapy
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 167, Issue 1, pp. 68 - 76.e2
Journal Article
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 08/2016, Volume 22, Issue 29, pp. 4577 - 4582
Background: Patients with ST-segment elevation myocardial infarction represent a high-risk population and an effective antiplatelet treatment adjunctive to... 
Prasugrel | Clopidogrel | Percutaneous coronary intervention | Ticagrelor | ST elevation myocardial infarction | clopidogrel | RESPONSE VARIABILITY | prasugrel | ticagrelor | TRITON-TIMI 38 | GENETIC-VARIANTS | DOSE CLOPIDOGREL | percutaneous coronary intervention | PLATELET INHIBITION | PHARMACOLOGY & PHARMACY | OUTCOMES | ELEVATION MYOCARDIAL-INFARCTION
Journal Article
American Heart Journal, ISSN 0002-8703, 2011, Volume 162, Issue 4, pp. 733 - 739
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 16, pp. 2091 - 2092
In the PEGASUS-TIMI 54 (Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis In Myocardial Infarction... 
TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | Care and treatment | Cardiac patients | Heart attack | Myocardial infarction | Stroke | Heart attacks | Clopidogrel | Infarction | Patients | Age
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 22, pp. 2433 - 2434
  No net clinical benefit from prasugrel compared with clopidogrel has been described, not only in the subgroup of patients >=75 years of age but also in those... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | INSIGHTS | REGISTRY | Drug therapy | Medical research
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2014, Volume 111, Issue 3, pp. 551 - 557
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 11, pp. 1223 - 1232
Abstract Physicians considering prescription of P2Y12 -receptor antagonist for long-term (>1 year) protection of patients post-myocardial infarction face the... 
Cardiovascular | Internal Medicine | clopidogrel | prasugrel | ticagrelor | thienopyridines | platelets
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.